Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalgesia in rats

被引:34
|
作者
Wang, FuZhou [1 ,2 ]
Shen, XiaoFeng [1 ]
Guo, XiRong [3 ]
Peng, YuZhu [3 ]
Liu, YuSheng [1 ]
Xu, ShiQin [1 ]
Yang, Jie [2 ]
机构
[1] Nanjing Med Univ, Affiliated Nanjing Matern & Child Hlth Care Hosp, Dept Anesthesiol, Nanjing 210004, Jiangsu, Peoples R China
[2] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Nanjing Matern & Child Hlth Care Hosp, Inst Pediat, Nanjing 210004, Jiangsu, Peoples R China
关键词
Macrophage migration inhibitory factor; Tautomerase; CD74; MAPK; N-methyl-D-aspartate; Inflammatory pain; CENTRAL-NERVOUS-SYSTEM; T-CELL-ACTIVATION; FACTOR MIF; FORMALIN TEST; UP-REGULATION; SUBARACHNOID SPACE; SIGNALING PATHWAY; FACTOR EXPRESSION; IMMUNE-RESPONSE; DORSAL-HORN;
D O I
10.1016/j.pain.2009.11.011
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Pro-inflammatory cytokine production after nociceptive stimuli is pivotal for hyperalgesia. As macrophage migration inhibitory factor (MIF), a pleiotropic cytokine produced mainly by nonneuronal tissue, has been involved in the regulation of neuronal functions, herein we examined the role for MIF in formalin-induced inflammatory pain model. MIF critically contributed to nociceptive behaviors following formalin injection. Specifically, spinal administration of a MIF inhibitor (ISO-1) prevented and reversed. inching responses in rats. Further examination showed that levels of both MIF and the MIF receptor CD74 were substantially increased within the ipsilateral spinal cord dorsal horn after formalin administration. Mechanistic studies revealed that MIF upregulated the expression of the spinal NMDA receptor subunit NR2B via the MAPK signaling pathway. Moreover, microglial cells were found to be the major source of spinal MIF after formalin administration by fluorescence colocalization. These data highlight spinal MIF plays a critical role in the pathogenesis of formalin-induced inflammatory pain and suggest MIF may be a potential target for therapy of such pathological condition. (C) 2009 International Association for the Study of Pain. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 50 条
  • [31] Macrophage migration inhibitory factor contributes to development of nonsteroidal anti-inflammatory drugs-induced gastric injury in mice
    Ohkawara, Tatsuya
    Takeda, Hiroshi
    Ohnishi, Shunsuke
    Kato, Mototsugu
    Nishihira, Jun
    Asaka, Masahiro
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (04) : 418 - 423
  • [32] MACROPHAGE MIGRATION INHIBITORY FACTOR IN THYMUS
    HOUCK, JC
    CHANG, CM
    PLATT, M
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1973, 143 (03): : 858 - 861
  • [33] Macrophage migration inhibitory factor in cancer
    Yasasever, Vildan
    Camlica, Hakan
    Duranyildiz, Derya
    Oguz, Hilal
    Tas, Faruk
    Dalay, Nejat
    CANCER INVESTIGATION, 2007, 25 (08) : 715 - 719
  • [34] Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome
    Gando, S
    Nishihira, J
    Kobayashi, S
    Morimoto, Y
    Nanzaki, S
    Kemmotsu, O
    INTENSIVE CARE MEDICINE, 2001, 27 (07) : 1187 - 1193
  • [35] The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis
    Santos, Leilani L.
    Morand, Eric F.
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2006, 156 (1-2) : 11 - 18
  • [36] Macrophage Migration Inhibitory Factor in Normal Human Skeletal Muscle and Inflammatory Myopathies
    Reimann, Jens
    Schnell, Susanne
    Schwartz, Stephanie
    Kappes-Horn, Karin
    Dodel, Richard
    Bacher, Michael
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (06): : 654 - 662
  • [37] Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease
    Oliver, J.
    Marquez, A.
    Gomez-Garcia, M.
    Martinez, A.
    Mendoza, J. L.
    Vilchez, J. R.
    Lopez-Nevot, M. A.
    Pinero, A.
    de la Concha, E. G.
    Nieto, A.
    Urcelay, E.
    Martin, J.
    GUT, 2007, 56 (01) : 150 - 151
  • [38] OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases
    Thiele, Michael
    Donnelly, Seamas C.
    Mitchell, Robert A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [39] Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection
    Javeed, A.
    Zhao, Y.
    Zhao, Y.
    INFLAMMATION RESEARCH, 2008, 57 (02) : 45 - 50
  • [40] Overview of the Role of Macrophage Migration Inhibitory Factor (MIF) in Inflammatory Bowel Disease
    Nishihira, Jun
    Mitsuyama, Keiichi
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (18) : 2104 - 2109